These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diffusion of contingency management and attitudes regarding its effectiveness and acceptability. Bride BE, Abraham AJ, Roman PM. Subst Abus; 2010 Jul; 31(3):127-35. PubMed ID: 20687001 [Abstract] [Full Text] [Related]
4. Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Aletraris L, Edmond MB, Paino M, Fields D, Roman PM. Subst Abus; 2016 Jul; 37(1):47-53. PubMed ID: 26168816 [Abstract] [Full Text] [Related]
5. Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine. Knudsen HK, Ducharme LJ, Roman PM. Am J Addict; 2007 Jul; 16(5):365-71. PubMed ID: 17882607 [Abstract] [Full Text] [Related]
8. Causation of drug abuse and treatment strategy: a comparison of counselors' perceptions of faith-based and secular drug treatment programs. Chu DC, Sung HE. Int J Offender Ther Comp Criminol; 2014 Apr; 58(4):496-515. PubMed ID: 23070954 [Abstract] [Full Text] [Related]
10. Counselor attitudes toward and use of evidence-based practices in private substance use disorder treatment centers: a comparison of social workers and non-social workers. Bride BE, Kintzle S, Abraham AJ, Roman PM. Health Soc Work; 2012 Aug; 37(3):135-45. PubMed ID: 23193729 [Abstract] [Full Text] [Related]
11. Experiential suicide prevention training for substance use treatment intensive outpatient program counselors: Stepped wedge cluster-randomized training study. Comtois KA, Huh D, Fruhbauerova M, Livengood A, Kerbrat A, Smythe P, Ries R. J Subst Use Addict Treat; 2024 Nov; 166():209397. PubMed ID: 38750957 [Abstract] [Full Text] [Related]
12. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R. Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864 [Abstract] [Full Text] [Related]
13. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Kirby KC, Benishek LA, Dugosh KL, Kerwin ME. Drug Alcohol Depend; 2006 Oct 15; 85(1):19-27. PubMed ID: 16650657 [Abstract] [Full Text] [Related]
14. Acceptability of contingency management among clinicians and clients within a co-occurring mental health and substance use treatment program. Srebnik D, Sugar A, Coblentz P, McDonell MG, Angelo F, Lowe JM, Ries RK, Roll J. Am J Addict; 2013 Oct 15; 22(5):432-6. PubMed ID: 23952887 [Abstract] [Full Text] [Related]
15. Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring. Cunningham C, Stitzer M, Campbell AN, Pavlicova M, Hu MC, Nunes EV. J Subst Abuse Treat; 2017 Jan 15; 72():134-139. PubMed ID: 26482136 [Abstract] [Full Text] [Related]
18. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study. Becker SJ, Scott K, Murphy CM, Pielech M, Moul SA, Yap KR, Garner BR. BMC Health Serv Res; 2019 Jul 09; 19(1):466. PubMed ID: 31288797 [Abstract] [Full Text] [Related]
19. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, Schwartz RP, Metsch L. J Subst Abuse Treat; 2018 Nov 09; 94():18-23. PubMed ID: 30243412 [Abstract] [Full Text] [Related]
20. Motivation and Contingency Management Treatments for Substance Use Disorders. Walter KN, Petry NM. Curr Top Behav Neurosci; 2016 Nov 09; 27():569-81. PubMed ID: 25762429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]